|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5550 EUR | -0.54% |
|
-9.39% | -63.54% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.54% | -9.39% | -35.48% | -51.97% | -63.54% | -54.98% | -86.49% | -96.34% | -95.99% | 50.96M | |
| +0.96% | +3.12% | +10.38% | +12.92% | +21.10% | +56.19% | +15.47% | +66.56% | +116.71% | 315B | |
| +0.26% | -2.28% | +2.93% | +18.43% | +11.66% | +25.65% | -11.82% | -19.49% | +40.47% | 67.93B | |
| -0.99% | +2.64% | +12.80% | +13.77% | +15.63% | +35.25% | +81.44% | +83.24% | +742.21% | 9.23B | |
| -1.26% | -1.95% | +3.59% | +10.36% | +2.65% | +2.83% | -4.98% | -30.55% | +34.61% | 8.43B | |
| -1.03% | -1.79% | -10.18% | -25.80% | -38.36% | -24.11% | -10.07% | -38.06% | - | 4.07B | |
| +0.38% | -9.58% | +3.69% | +37.45% | +30.03% | -5.58% | +22.13% | -34.73% | - | 3.77B | |
| +0.86% | +1.01% | -4.36% | -26.18% | -37.54% | -43.84% | +10.01% | +32.14% | +70.03% | 3.54B | |
| -1.94% | -1.66% | +5.53% | -6.66% | -5.55% | +43.68% | +53.35% | +71.88% | +123.20% | 2.72B | |
| -2.81% | -6.33% | +9.07% | -14.50% | -16.62% | +5.13% | -9.94% | +45.29% | - | 2.13B | |
| +2.66% | -6.39% | +18.24% | -4.09% | +1.81% | -18.43% | +36.47% | -29.33% | - | 1.95B | |
| +0.57% | -3.63% | +5.93% | -10.25% | -13.27% | -21.58% | -17.67% | -10.61% | -43.08% | 1.73B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| -0.05% | -8.11% | -1.87% | -26.25% | -15.13% | -36.56% | -30.60% | - | - | 1.21B | |
| +0.88% | +13.19% | +33.19% | +84.58% | +157.72% | +198.70% | +1,367.34% | +665.91% | - | 1.19B | |
| -6.56% | -6.73% | -14.78% | -43.19% | -43.06% | +30.70% | +22.73% | +11.60% | +410.45% | 1.06B | |
| +0.83% | -18.71% | +12.79% | +4.85% | +13.85% | -13.84% | +91.88% | +6.98% | - | 1.14B | |
| +0.72% | +0.60% | +5.24% | -7.05% | -9.25% | +1.20% | +39.74% | +85.90% | +75.54% | 1.06B | |
| -1.30% | -5.70% | +0.77% | -20.81% | -23.75% | -36.54% | -75.64% | -84.79% | - | 878M | |
| +1.25% | -3.57% | -0.82% | -13.21% | -12.59% | -43.22% | -10.99% | -48.41% | -65.24% | 869M | |
| Average | -0.31% | -3.06% | +2.98% | -3.56% | -1.27% | +5.30% | +78.02% | +37.62% | +128.08% | 21.47B | |
| Weighted average by Cap. | +0.68% | +2.84% | +8.63% | +12.60% | +17.42% | +46.06% | +15.68% | +49.16% | +115.68% |
- Stock Market
- Stocks
- AB Stock
- Sector AB Science
Select your edition
All financial news and data tailored to specific country editions
